¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽŰæ¸é¿ªÇÐȸ 2023³â ÇÏ°èÇмú´ëȸ : 2023-08-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽŰæ¸é¿ªÇÐȸ 2023³â ÇÏ°èÇмú´ëȸ : 2023-08-12
±³À°ÀÏÀÚ : 2023-08-12
±³À°Àå¼Ò : º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë (¿ÀÇÁ¶óÀÎ °³ÃÖ)

±³À°ÁÖÁ¦ : ´ëÇѽŰæ¸é¿ªÇÐȸ 2023³â ÇÏ°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ¸é¿ªÇÐȸ

´ã´çÀÚ : ´ëÇѽŰæ¸é¿ªÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-720-1594

À̸ÞÀÏ : ksms1594@daum.net

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 90,000¿ø  

ºñ°í »çÀüµî·Ï: Àü°øÀÇ(ȸ¿ø) 2¸¸¿ø, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø / ´çÀϵî·Ï: Àü°øÀÇ(ȸ¿ø) 3¸¸¿ø, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 5¸¸¿ø, ºñȸ¿ø 9¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 09:10~09:35 Multiple Sclerosis (MS) ¹ÚÁø¿ì(°í·ÁÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 09:35~10:00 Neuromyelitis Optica Spectrum Disorder(NMOSD) & Myelin oligodendrocyte glycoprotein antibody-associated disease(MOGAD) ±è±âÈÆ(±¹¸³¾Ï¼¾ÅÍ ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 10:00~10:20 Autoimmune encephalitis (AE) ÀåÀ±Çõ(¼­¿ïÀÇ´ë ½Å°æ°ú)

Åä·Ð 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 10:20~10:30 Q&A ( )

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 10:45~11:05 Infection as a trigger factor of Multiple Sclerosis (MS) ÀÌÀºÀç(¿ï»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 11:05~11:25 Vitamin D deficiency and supplementation in Multiple Sclerosis (MS) ¹ÎÁÖÈ«(¼º±Õ°üÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 11:25~11:45 Diet and exercise ±èÁؼø(¼­¿ïÀÇ´ë ½Å°æ°ú)

Åä·Ð 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 11:45~11:55 Q&A ( )

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 11:55~12:35 Tolerogenic Nanovaccine for Multiple Sclerosis ±èÀçÀ±(¼º±Õ°ü´ë È­ÇаøÇаú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 13:20~13:50 Scientific session ¥°(Neuroimmunology & Multiple Sclerosis (MS)) ¹ÎÁÖÈ«(¼º±Õ°üÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 13:50~14:20 Tolerogenic Nanovaccine for Multiple Sclerosis ±è¼º¹Î(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 14:20~15:05 Scientific session ¥± (Neuroimmunology & Multiple Sclerosis (MS)) ±è¼öÇö ¼®Èï¿­(±¹¸³¾Ï¼¾ÅÍ °è¸íÀÇ´ë)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 15:20~15:40 Progression Independent of Relapse Activity in Relapsing-remitting multiple sclerosis ±Ç¿µ³²(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 15:40~16:00 Diagnosis of Progressive multiple sclerosis ÇöÀç¿ø(±¹¸³¾Ï¼¾ÅÍ ½Å°æ°ú)

±³À°½Ã°£ 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 16:00~16:20 Treatments in Progressive multiple sclerosis ±è¿ìÁØ(°¡Å縯ÀÇ´ë ½Å°æ°ú)

Åä·Ð 08¿ù 12ÀÏ º¸ÄÚ°­³²¼­¿ï LLÃþ(B2) º¼·ë 16:20~16:30 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽŰæ¸é¿ªÇÐȸ 2023³â ÇÏ°èÇмú´ëȸ : 2023-08-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ´ëÇѽŰæ°úÇÐȸ ³ú½Å°æÁ¶ÀýÄ¡·á ½ÉÆ÷Áö¾ö : 2023-08-12
´ÙÀ½±Û ´ëÇѵΰæºÎ¿Ü°úÇÐȸ 19th Head and Neck Seoul Forum : 2023-08-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷